Jianfeng Group Lin2016 -006 (Announcement of 906 Board Resolution)
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 编号:临2016-006
债券简称:13尖峰01 债券代码:122227
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
九届六次董事会决议公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
一、董事会会议召开情况
(一)本次董事会会议的召集、召开符合有关法律、法规及公司《章程》的相关规定。
(二)2016年3月28日,公司以传真、电子邮件及专人送达的方式发出了本次董事会会议通知。
(三)2016年4月8日,本次董事会会议在浙江省金华市尖峰大厦三楼会议室以现场表决方式召开。
(四)本次董事会会议应出席的董事8人,实际出席会议的董事8人,会议有效表决票数8票。
(五)本次董事会由董事长蒋晓萌主持,公司监事和高级管理人员列席会议。
二、董事会会议审议情况
1、通过了2015年度总经理业务报告
经审议,董事会一致通过了该报告。
表决结果:同意8票、反对0票、弃权0票。
2、通过了2015年度财务决算报告
董事会审议并通过了该报告,本议案需提交股东大会审议。
表决结果:同意8票、反对0票、弃权0票。
3、通过了2015年度利润分配议案
经天健会计师事务所审计,2015年度公司合并报表归属于母公司股东的净利润为200,899,362.77 元;母公司会计报表净利润140,843,091.13元。按母公司的本期净利润140,843,091.13元为基数,提取10%法定公积金14,084,309.11元,加年初未分配利润407,611,924.40元,减去2014年度现金分红86,020,957.00元,本年度可供分配利润为448,349,749.42元。
公司2015年度拟进行现金分配,以2015年末股本344,083,828股为基数,每10股派发现金红利1.80元(含税),向股权登记日登记在册的全体股东派发现金股利总额为61,935,089.04元(含税)。
2015年度不进行公积金转增股本。
该预案将提交股东大会审议。
表决结果:同意8票、反对0票、弃权0票。
4、通过了聘请公司2016年度审计机构的议案
董事会审议并通过了该议案,同意聘请天健会计师事务所为公司2016年度财务及内部控制审计机构。本议案需提交股东大会审议。
表决结果:同意8票、反对0票、弃权0票。
5、通过了2015年年度报告及其摘要
董事会审议并通过了该报告,本议案需提交股东大会审议。
表决结果:同意8票、反对0票、弃权0票。
2015年度报告全文及摘要详见上海证券交易所网站(www.sse.com.cn)。
6、通过了关于对控股子公司提供担保的议案
董事会一致通过了该议案,同意为控股子公司提供以下担保事宜。
(1)对控股子公司向金融机构借款提供担保,设定如下额度:
|
被担保单位 |
设定担保额度(万元) |
|
大冶尖峰水泥有限公司 |
10000 |
|
浙江尖峰药业有限公司 |
30000 |
|
金华市医药公司 |
15000 |
|
浙江尖峰国际贸易有限公司 |
5000 |
|
云南尖峰水泥有限公司 |
5000 |
|
合计 |
65000 |
(2)同意为浙江尖峰国际贸易有限公司提供担保函,为浙江尖峰国际贸易有限公司的客户在该公司存放的货物提供相应的担保。
在以上额度内的担保授权董事长分次执行。
本议案需提交股东大会审议。
表决结果:同意8票、反对0票、弃权0票。
详见《对控股子公司提供担保的公告》(临2016-008)。
7、通过了与浙江凯恩特种材料股份有限公司互相担保的议案
董事会审议并通过了该议案,同意与浙江凯恩特种材料股份有限公司进行额度为5000万元、期限为一年的等额互保。
本议案需提交股东大会审议。
表决结果:同意8票、反对0票、弃权0票。
详见《与浙江凯恩特种材料股份有限公司互相担保的公告》(临2016-009)。
8、通过了2015年度内部控制评价报告
董事会审议并通过了该报告。
表决结果:同意8票、反对0票、弃权0票。
内部控制评价报告详见上海证券交易所网站(www.sse.com.cn)。
9、通过了关于修改内控手册的议案
董事会审议并通过了该议案,同意对内控手册中的部分制度进行修订。
表决结果:同意8票、反对0票、弃权0票。
本次修订的内控手册中的《尖峰集团筹资管理制度》和《尖峰集团对外投资管理制度》详见上海证券交易所网站(http://www.sse.com.cn)。
10、通过了2015年度《中长期激励基金计提方案》
董事会审议并通过了该议案。根据《中长期激励管理办法》的规定,提取2015年度中长期激励基金为6213382.35元。
表决结果:同意8票、反对0票、弃权0票。
11、通过了关于增补独立董事的议案
董事会审议并通过了该议案。公司董事会同意提名孙宏斌先生为本公司独立董事候选人,提交股东大会选举。简历见附件。
表决结果:同意8票、反对0票、弃权0票。
12、通过了关于对天士力集团增资的关联交易议案
董事会审议并通过了该议案。关联董事蒋晓萌先生、杜自弘先生回避了该项议案的表决。
表决结果:同意6票、反对0票、弃权0票。
该报告将提交股东大会审议。
详见《关于对天士力集团增资的关联交易公告》(临2016-010)。
13、通过了关于对尖峰药业增资的关联交易议案
董事会审议并通过了该报告。关联董事蒋晓萌先生回避了该项议案的表决。
表决结果:同意7票、反对0票、弃权0票。
详见《关于对尖峰药业增资的关联交易公告》(临2016-011)。
公司独立董事事前对第12、13两个事项进行了审议,认为:上述两项关联交易的增资价格依据经审计的净资产决定,且按各股东持股比例享有增资权,公司参与增资后能确保不降低所占的股权份额。上述关联交易实施后将有效优化被投资公司的资产结构,增强企业实力、提升竞争力,确保企业持续健康发展。以上关联交易没有损害公司及股东的利益,同意将该议案提交给公司第九届董事会第6次会议审议。
董事会审计委员会对第12、13两个事项发表了审核意见:认为上述关联交易属于公司正常的经济行为,符合公司经营发展需要;增资的价格都依据经审计的净资产决定,且按各股东持股比例享有增资权,增资后本公司所占被投资单位的股权份额不会下降;交易遵循了公平、公正、自愿、诚信的原则,没有损害公司及股东的利益,予以同意。
14、通过了关于召开2015年度股东大会的议案
董事会决定于2016年5月9日在浙江省金华市婺江东路88号尖峰大厦召开2015年度股东大会。
表决结果:同意8票、反对0票、弃权0票
详见《关于召开2015年度股东大会的通知》(临2016-012)。
15、通过了2015年度独立董事述职报告
董事会审议并通过了该报告。
表决结果:同意8票、反对0票、弃权0票
独立董事将向股东大会报告。
16、通过了董事会审计委员会2015年度履职报告
董事会审议并通过了该报告。
表决结果:同意8票、反对0票、弃权0票
17、通过了2015年度董事会工作报告
表决结果:同意8票、反对0票、弃权0票。
该报告将提交股东大会审议。
公司独立董事的独立意见:
公司独立董事对上述3、4、6、7、10、11、12、13八项决议发表了独立意见,认为:该决议的形成符合《公司法》、公司《章程》等有关规定,没有损害中小股东的利益。
三、上网公告附件
公司第九届独立董事对上述相关事项的独立董事意见,对关联交易事项的事前认可声明;审计委员会对关联交易事项的书面审核意见。
特此公告
浙江尖峰集团股份有限公司董事会
二〇一六年四月十二日
附件:
孙宏斌先生,1966年12月出生,理学博士、教育部“长江学者”特聘教授。先后在中科院上海有机化学研究所、德国亚琛工业大学和美国佛罗里达大学从事博士后研究工作,在美国加州Metabolex公司从事新药研究工作。现任中国药科大学教授、博士生导师、新药研究中心主任,兼任江苏省代谢性疾病药物重点实验室主任、“天然药物活性组分与药效”国家重点实验室副主任、中国药学会药物化学专业委员会委员、江苏省药学会药物化学专业委员会副主任委员、中国药科大学学位评定委员会和学术委员会委员、国家基金委医学部“十三五”发展战略研究“药物学”专家组副组长、国家技术发明奖会议评审专家、江苏威凯尔医药科技有限公司名誉董事长等职。
More information
The company's "three" cultivation through the stage of acceptance
Since November 2015 was included in the second batch of "three" cultivation pilot enterprises in Zhejiang Province, the company has carried out a series of related work in depth. On October 19, the implementation of the company's "three" cultivation project from January 2016 to September 2017 passed the phased acceptance organized by Jinhua Economic and Information Commission and Jinhua Finance Bureau. According to the requirements of the "three" cultivation pilot enterprise responsibility letter signed with Zhejiang Province, Jinhua City and Wucheng District, as of the end of September 2017, the company has invested 16.0772 million yuan in related projects, and has achieved remarkable results in improving management, improving automation and informatization level. For example, after the digital system of quality and cost control in the plant extraction workshop of Jianfeng Health Technology Company is put into use, the whole production process can be controlled and traceable, the product quality is more stable, the production safety is effectively guaranteed, the "three wastes" emission is greatly reduced, and the product cost is reduced by 20%. The electronic label system of the pharmaceutical company automatically addresses and accurately locates the drugs in and out of the warehouse, which reduces the error rate of the out and into the warehouse, and the location management can automatically display the information such as the location and quantity of the drugs, which improves the work efficiency of the warehouse logistics and effectively reduces the management cost. The pharmaceutical company's sales management information system integrates sales management, warehouse management, customer management, statistical analysis and other modules, realizes drug sales management and control functions according to the requirements of GMP and GSP specifications, and analyzes drug regions and sales volume through big data, which will judge drug consumption trends faster and more accurately and improve the accuracy of the company's drug sales decisions. Health
2020
07-31
The company's "three" cultivation through the stage of acceptance
Since November 2015 was included in the second batch of "three" cultivation pilot enterprises in Zhejiang Province, the company has carried out a series of related work in depth. On October 19, the implementation of the company's "three" cultivation project from January 2016 to September 2017 passed the phased acceptance organized by Jinhua Economic and Information Commission and Jinhua Finance Bureau. According to the requirements of the "three" cultivation pilot enterprise responsibility letter signed with Zhejiang Province, Jinhua City and Wucheng District, as of the end of September 2017, the company has invested 16.0772 million yuan in related projects, and has achieved remarkable results in improving management, improving automation and informatization level. For example, after the digital system of quality and cost control in the plant extraction workshop of Jianfeng Health Technology Company is put into use, the whole production process can be controlled and traceable, the product quality is more stable, the production safety is effectively guaranteed, the "three wastes" emission is greatly reduced, and the product cost is reduced by 20%. The electronic label system of the pharmaceutical company automatically addresses and accurately locates the drugs in and out of the warehouse, which reduces the error rate of the out and into the warehouse, and the location management can automatically display the information such as the location and quantity of the drugs, which improves the work efficiency of the warehouse logistics and effectively reduces the management cost. The pharmaceutical company's sales management information system integrates sales management, warehouse management, customer management, statistical analysis and other modules, realizes drug sales management and control functions according to the requirements of GMP and GSP specifications, and analyzes drug regions and sales volume through big data, which will judge drug consumption trends faster and more accurately and improve the accuracy of the company's drug sales decisions. Health
2020
07-30
Yunnan Jianfeng supplies cement directly to Wa State of Myanmar
Yunnan Jianfeng Cement Company not only consolidates the original domestic market, but also gives full play to the location advantages of the three counties (Lancang, Menglian and Ximeng) close to the border to continuously expand the foreign market. Recently, the marketing department took the initiative to step out of the country from the Mangxin port in Menglian County and successfully sold "Jianfeng" brand cement to the newly planned Jinhua Xiaozunhe Island Development Zone in the Wa State of Myanmar. With the rapid development of China's economy in recent years, Myanmar has also increased the development of the China-Myanmar border area year by year. In order to attract more Chinese tourists to spend in transit, the Wa State Government of Myanmar has planned the Jinhua Xiaozunhe Island Development Zone near China's Menglian Mangxin Port. After the development zone is completed, it will mainly focus on gambling, business hotels, and border trade. There is an estimated demand for about 80000 tons of cement. When Yunnan Jianfeng marketing personnel learned of the news, they went deep into the development zone many times to understand the situation and had extensive contact with customers. With the good reputation of Jianfeng Cement in southwest Yunnan in recent years, they successfully signed a supply contract with a commercial mixing station in the development zone. At present, Yunnan Jianfeng has directly supplied 1200 tons of cement through Mangxin Port, and is expected to win 80% of the cement supply business of the development project. The initiative of "Belt and Road Initiative" to open up the international channels of South Asia and Southeast Asia has brought new development opportunities to many enterprises. This time, Yunnan Jianfeng Marketing Department went abroad to seize the opportunity, breaking the previous practice that the company mainly relied on agents for cement export, and achieved a new breakthrough in directly connecting users, which not only increased revenue, but also further expanded the radiation scope of its own marketing network, so as to further expand the scope of going abroad in the future.
2020
07-31
The company's "three" cultivation through the stage of acceptance
Since November 2015 was included in the second batch of "three" cultivation pilot enterprises in Zhejiang Province, the company has carried out a series of related work in depth. On October 19, the implementation of the company's "three" cultivation project from January 2016 to September 2017 passed the phased acceptance organized by Jinhua Economic and Information Commission and Jinhua Finance Bureau. According to the requirements of the "three" cultivation pilot enterprise responsibility letter signed with Zhejiang Province, Jinhua City and Wucheng District, as of the end of September 2017, the company has invested 16.0772 million yuan in related projects, and has achieved remarkable results in improving management, improving automation and informatization level. For example, after the digital system of quality and cost control in the plant extraction workshop of Jianfeng Health Technology Company is put into use, the whole production process can be controlled and traceable, the product quality is more stable, the production safety is effectively guaranteed, the "three wastes" emission is greatly reduced, and the product cost is reduced by 20%. The electronic label system of the pharmaceutical company automatically addresses and accurately locates the drugs in and out of the warehouse, which reduces the error rate of the out and into the warehouse, and the location management can automatically display the information such as the location and quantity of the drugs, which improves the work efficiency of the warehouse logistics and effectively reduces the management cost. The pharmaceutical company's sales management information system integrates sales management, warehouse management, customer management, statistical analysis and other modules, realizes drug sales management and control functions according to the requirements of GMP and GSP specifications, and analyzes drug regions and sales volume through big data, which will judge drug consumption trends faster and more accurately and improve the accuracy of the company's drug sales decisions. Health
2020
07-31
"We were also praised by the traffic police." On September 26, when talking about the civilized travel volunteer activities a few days ago, Li Xuegen of the big pharmacy smiled and was very happy that his work was recognized. Starting from May this year, during the rush hour on the 5th and 20th of each month (weekends and holidays are postponed), there will be a group of volunteers wearing red vests and hats, holding signs with the words "courtesy of zebra crossing, civilized crossing of the road" to divert traffic at many intersections in the city. This is a civilized travel volunteer service activity carried out by Jinhua City to further promote civilized travel and persuade uncivilized behavior. As a civilized unit at the municipal level in Jinhua, Jianfeng Group's duty junction is at the intersection of Bayi North Street and Zhongshan West Road. Before the activity was carried out, as the organizer of the group company, the group office had deep concerns. The activity took a long time and required a lot of manpower. As an enterprise, under the condition of ensuring normal production, it was completed by employees in their spare time. Can it be continued? To this end, Xiang Chongping, the leader in charge of the group company, specially organized a meeting of the directors of the subordinate enterprise offices to mobilize and deploy the matter. The group office also specially established the QQ group of "Peak Civilized Travel Volunteer Service" to release the contents and arrangements of the activities, update the duty situation, and praise the small partners on duty. At the beginning of the activity, colleagues in the headquarters building took the lead in taking up their posts. The first class was Li Hong, Li Xia, Yang Liu and Lei Yuan of the finance department of the group company. Employees of the group office, the peak health experience hall, Qiubin Factory and the international trading company also took up their posts one after another. Other enterprises also took part in an orderly manner according to the duty schedule.
2020
07-31
Daye peak again won the national inspection big contrast "all-excellent award"
A few days ago, daye peak cement co., ltd won the "all-excellent award" in the 16th national cement quality index inspection comparison of "hongchao science and technology cup" organized by the national cement quality supervision and inspection center in 2017 ". The national cement quality index inspection is held every two years. It is the highest level competition in the cement industry. It aims to understand the current quality inspection level of China's cement industry through large-scale comparison, promote various cement inspection departments to improve the inspection quality, and provide accurate data for cement production and use. The results truly reflect the overall inspection level of national cement production enterprises and provincial building materials (cement) inspection stations, it represents the highest level of inspection technology in the cement industry. Over the years, Daye Peak has firmly established the concept of "quality is the life of an enterprise", always puts product quality control in the first place, and conducts daily inspections in strict accordance with the testing items and frequency specified by national standards. actively carry out inspection comparison with provincial and municipal cement quality inspection centers, improve the professional level of inspectors through skill training, and spot check the internal passwords of inspectors every month to strictly ensure the accuracy and reliability of data, to ensure that the quality of the factory cement to meet the market and customer demand, and further enhance the core competitiveness of enterprises. Since it was officially put into production in 2008, Daye Peak has participated in the national cement quality index inspection five times, and has achieved good results. Among them, it won the "All-Excellent Award" in 2009 and the "All-Qualified" in 2011, 2013 and 2015. Unit Award ". (Yang Huiping)
2020
07-31